75
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Maternal smoking during pregnancy and risk of phacomatoses: results from a Swedish register-based study

ORCID Icon, , &
Pages 793-800 | Published online: 03 Sep 2019

References

  • Rosser T. Neurocutaneous disorders. Continuum (Minneap Minn). 2018;24(1,Child Neurology):96–129. doi:10.1212/CON.000000000000056229432239
  • Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23(2):276–292. doi:10.1200/JCO.2005.10.04215637391
  • Kerrison JB, Newman NJ. The phacomatoses. Neurosurg Clin N Am. 1999;10(4):775–87,x.10529983
  • Stefanaki K, Alexiou GA, Stefanaki C, et al. Tumors of central and peripheral nervous system associated with inherited genetic syndromes. Pediatr Neurosurg. 2012;48(5):271–285. doi:10.1159/00035154623796843
  • Johansson G, Andersson U, Melin B. Recent developments in brain tumor predisposing syndromes. Acta Oncol. 2016;55(4):401–411. doi:10.3109/0284186X.2015.110719026634384
  • Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327–332. doi:10.1002/ajmg.a.3313920082463
  • Melean G, Sestini R, Ammannati F, et al. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet. 2004;129C(1):74–84. doi:10.1002/ajmg.c.3002215264275
  • Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus G. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243–254. doi:10.1016/j.pediatrneurol.2013.08.00124053982
  • van Minkelen R, van Bever Y, Kromosoeto JN, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85(4):318–327. doi:10.1111/cge.1218723656349
  • Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368(21):1971–1979. doi:10.1056/NEJMoa121350723656586
  • Snajderova M, Riccardi VM, Petrak B, et al. The importance of advanced parental age in the origin of neurofibromatosis type 1. Am J Med Genet A. 2012;158A(3):519–523. doi:10.1002/ajmg.a.3441322302476
  • Liu Q, Zoellner N, Gutmann DH, et al. Parental age and neurofibromatosis type 1: a report from the NF1 patient registry initiative. Fam Cancer. 2015;14(2):317–324. doi:10.1007/s10689-014-9774-825523354
  • Adel Fahmideh M, Tettamanti G, Lavebratt C, et al. Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study. Clin Epidemiol. 2018;10:729–738. doi:10.2147/CLEP.S15918329950902
  • Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;6(Suppl 2):S125–S140. doi:10.1080/1462220041000166918715203816
  • Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17(5):589–604. doi:10.1093/humupd/dmr02221747128
  • Hook EB, Cross PK. Cigarette smoking and Down syndrome. Am J Hum Genet. 1985;37(6):1216–1224.2934980
  • Christianson RE, Torfs CP. Maternal smoking and Down syndrome. Am J Hum Genet. 1988;43(4):545–547.2972201
  • Kline J, Levin B, Stein Z, et al. Cigarette smoking and trisomy 21 at amniocentesis. Genet Epidemiol. 1993;10(1):35–42. doi:10.1002/gepi.13701001058472933
  • Cuckle HS, Alberman E, Wald NJ, et al. Maternal smoking habits and Down’s syndrome. Prenat Diagn. 1990;10(9):561–567.2148372
  • Kallen K.Down’s syndrome and maternal smoking in early pregnancy. Genet Epidemiol. 1997;14(1):77–84. 10.1002/(SICI)1098-2272(1997)14:1<77::AID-GEPI6>3.0.CO;2-2.9055063
  • Yang Q, Sherman SL, Hassold TJ, et al. Risk factors for trisomy 21: maternal cigarette smoking and oral contraceptive use in a population-based case-control study. Genet Med. 1999;1(3):80–88. doi:10.1097/00125817-199903000-0000411336457
  • Cnattingius S, Ericson A, Gunnarskog J, et al. A quality study of a medical birth registry. Scand J Soc Med. 1990;18(2):143–148.2367825
  • Ekbom A. The Swedish multi-generation register. Methods Mol Biol. 2011;675:215–220. doi:10.1007/978-1-59745-423-0_1020949391
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi:10.1186/1471-2458-11-45021658213
  • Brooke HL, Talback M, Hornblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–773. doi:10.1007/s10654-017-0316-128983736
  • Jadayel D, Fain P, Upadhyaya M, et al. Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature. 1990;343(6258):558–559. doi:10.1038/343558a02105472
  • Stephens K, Kayes L, Riccardi VM, et al. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet. 1992;88(3):279–282. doi:10.1007/bf001972591346385
  • Kluwe L, Mautner V, Parry DM, et al. The parental origin of new mutations in neurofibromatosis 2. Neurogenetics. 2000;3(1):17–24.11085592
  • Kresak JL, Walsh M. Neurofibromatosis: a review of NF1, NF2, and Schwannomatosis. J Pediatr Genet. 2016;5(2):98–104. doi:10.1055/s-0036-157976627617150
  • Doria-Rose VP, Kim HS, Augustine ET, et al. Parity and the risk of down’s syndrome. Am J Epidemiol. 2003;158(6):503–508. doi:10.1093/aje/kwg19312965874